Pathstone Holdings’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-143,719
Closed -$2.22M – 2201
2025
Q1
$2.22M Sell
143,719
-591,123
-80% -$9.03M 0.01% 923
2024
Q4
$11.2M Sell
734,842
-88,754
-11% -$1.43M 0.05% 269
2024
Q3
$13.5M Sell
823,596
-1,185,492
-59% -$19.4M 0.06% 236
2024
Q2
$33M Sell
2,009,088
-276,902
-12% -$4.45M 0.15% 99
2024
Q1
$38.1M Buy
2,285,990
+133,758
+6% +$2.07M 0.18% 84
2023
Q4
$32.2M Buy
+2,152,232
New +$31.3M 0.17% 91

Other funds holding BCAT

Pathstone Holdings's BCAT Position: Q2 2025 in Review

Pathstone Holdings sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2025, closing a stake of 143,719 shares — an estimated $2.22M sold.

Pathstone Holdings first reported a position in BCAT in Q4 2023 and held it in 6 quarters. The position peaked at $38.1M in Q1 2024. 91 funds tracked by Wall St. Rank hold BCAT as of Q2 2025.

  • Pathstone Holdings reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2025 after selling out during the quarter.
  • Pathstone Holdings sold 143,719 BlackRock Capital Allocation Term Trust shares in Q2 2025, an estimated $2.22M.
  • Pathstone Holdings first reported a position in BlackRock Capital Allocation Term Trust in Q4 2023 and held it in 6 quarters.
  • Pathstone Holdings's BlackRock Capital Allocation Term Trust position peaked at $38.1M in Q1 2024.
  • 91 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2025.

Based on Pathstone Holdings's 13F filing for Q2 2025, filed 12 Aug 2025.